2seventy bio Ownership | Who Owns 2seventy bio?

Overview Forecast RevenueFinancials Chart Transcripts

2seventy bio Ownership Summary

2seventy bio is owned by 15.12% institutional investors, 6.44% insiders, and 78.44% retail investors. Goldman sachs group is the largest institutional shareholder, holding 8.22% of TSVT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.87% of its assets in 2seventy bio shares.

TSVT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	2seventy bio	15.12%	6.44%	78.44%
Sector	Healthcare Stocks	479.67%	11.03%	-390.70%
Industry	Biotech Stocks	295.80%	10.97%	-206.77%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Goldman sachs group	4.29M	8.22%	$12.63M
Blackrock	3.66M	7.03%	$14.09M
Morgan stanley	3.27M	6.28%	$12.59M
Cowen and company	800.00K	1.54%	$3.08M
Bank of america corp /de/	606.78K	1.17%	$2.34M
Millennium management	212.30K	0.40%	$1.05M
Fmr	159.20K	0.30%	$468.05K
Jacobs levy equity management	146.31K	0.28%	$563.31K
Nuveen asset management	103.65K	0.20%	$304.72K
Alliancebernstein	65.98K	0.13%	$193.97K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cowen and company	800.00K	0.08%	$3.08M
Skyview investment advisors	12.50K	0.01%	$48.00K
Nverses capital	2.30K	0.01%	$8.86K
Skopos labs	5.99K	0.01%	$17.60K
China universal asset management	10.94K	0.00%	$32.16K
Jacobs levy equity management	146.31K	0.00%	$563.31K
Goldman sachs group	4.29M	0.00%	$12.63M
Morgan stanley	3.27M	0.00%	$12.59M
Millennium management	212.30K	0.00%	$1.05M
Public employees retirement system of ohio	25.81K	0.00%	$99.36K

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	212.30K	0.00%	163.53K
Bank of america corp /de/	606.78K	0.00%	76.71K
Goldman sachs group	4.29M	0.00%	75.08K
Susquehanna group, llp	33.20K	-	33.20K
Bnp paribas arbitrage, snc	12.07K	-	12.07K

Top Sellers

Holder	Shares	% Assets	Change
Kynam capital management, lp	-	-	-5.95M
Beryl capital management	-	-	-4.25M
Blackrock funding, inc. /de	-	-	-3.97M
Vanguard group	-	-	-2.82M
Newtyn management	-	-	-2.53M

New Positions

Holder	Shares	% Assets	Change	Value
Bnp paribas arbitrage, snc	12.07K	-	12.07K	$35.49K
China universal asset management	10.94K	0.00%	10.94K	$32.16K
Skopos labs	5.99K	0.01%	5.99K	$17.60K
Nverses capital	2.30K	0.01%	2.30K	$8.86K
Comerica bank	835.00	-	835.00	$3.21K

Sold Out

Holder	Change
Harbour investments	-1.00
Concord wealth partners	-2.00
Assetmark	-2.00
Clean yield group	-3.00
Cullen/frost bankers	-3.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	13	-88.89%	8,020,434	-82.55%	15	0.20%	8	-85.71%	1	-96.15%
Dec 31, 2024	60	-48.28%	18,921,267	-57.97%	36	0.49%	29	-27.50%	10	-72.22%
Sep 30, 2024	115	0.88%	45,002,708	-5.48%	86	1.03%	40	-24.53%	37	19.35%
Jun 30, 2024	114	-3.39%	47,611,917	1.78%	91	1.10%	53	17.78%	31	-29.55%
Mar 31, 2024	118	-0.84%	46,778,114	-2.93%	91	1.03%	45	-8.16%	44	22.22%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.53M	2.87%	-
iShares Russell 2000 ETF	1.23M	2.31%	208.00
Man Event Driven Alternative IN USD	1.16M	2.18%	1.16M
Vanguard Institutional Extnd Mkt Idx Tr	782.28K	1.47%	1.93K
Vanguard Strategic Equity Inv	702.79K	1.36%	-
Xtrackers S&P 500 2xLev Dly Swap ETF 1C	655.12K	1.27%	-
Fidelity Small Cap Index	498.31K	0.94%	11.22K
JPM Thematics Genetic Thrps C2 Acc USD	457.93K	0.89%	-16.10K
iShares Russell 2000 Value ETF	470.95K	0.88%	-1.60K
JPM Thematics Genetic Thrps C2 dist USD	441.82K	0.86%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 17, 2025	Snow Jessica	Chief Operating Officer	Sell	$11.36K
Mar 17, 2025	Baird William D III	President and CEO	Sell	$25.18K
Mar 17, 2025	Eatwell Victoria	Chief Financial Officer	Sell	$12.82K
Mar 11, 2025	Kynam Global Healthcare Master Fund, LP	-	Sell	$25.35M
Jan 06, 2025	Snow Jessica	See Remarks	Sell	$5.14K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	15
2024 Q4	-	4
2024 Q3	-	4
2024 Q2	-	3

TSVT Ownership FAQ

Who Owns 2seventy bio?

2seventy bio shareholders are primarily institutional investors at 15.12%, followed by 6.44% insiders and 78.44% retail investors. The average institutional ownership in 2seventy bio's industry, Biotech Stocks , is 295.80%, which 2seventy bio falls below.

Who owns the most shares of 2seventy bio?

2seventy bio’s largest shareholders are Goldman sachs group (4.29M shares, 8.22%), Blackrock (3.66M shares, 7.03%), and Morgan stanley (3.27M shares, 6.28%). Together, they hold 21.53% of 2seventy bio’s total shares outstanding.

Does Blackrock own 2seventy bio?

Yes, BlackRock owns 7.03% of 2seventy bio, totaling 3.66M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.09M$. In the last quarter, BlackRock decreased its holdings by -244K shares, a -6.26% change.

Who is 2seventy bio’s biggest shareholder by percentage of total assets invested?

Cowen and company is 2seventy bio’s biggest shareholder by percentage of total assets invested, with 0.08% of its assets in 800K 2seventy bio shares, valued at 3.08M$.

Who is the top mutual fund holder of 2seventy bio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of 2seventy bio shares, with 2.87% of its total shares outstanding invested in 1.53M 2seventy bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools